Antonia SJ, L ópez -Martin JA, Bendell J, et al. Nivolumab alone and nivolumab plus ipilimumab in recurrent small -cell lung cancer (CheckMate 032): a multicentre, open -label, phase 1/2 trial. L ancet Oncology June 2016, doi: 10.1016/S1470- 2045(16)30098-5 120.